This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.
Skyrocketing insulin prices put millions at risk of rationing the lifesaving drug. But policy fixes like capping costs seek to ease the affordability crisis.
